Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Cancer Research|November 1, 1985
Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cellsJ K Willson, B H Long, S Chakrabarty, et al.The Journal of Antibiotics|May 1, 1987
Production and biological activity of rebeccamycin, a novel antitumor agentJ A Bush, B H Long, J J Catino, et al.Journal of the National Cancer Institute|October 1, 1984
Effects of mitomycin on human colon carcinoma cellsB H Long, J K Willson, D E Brattain, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Preclinical pharmacology of BMS-275183, an orally active taxaneW C Rose, B H Long, C R Fairchild, et al.Anticancer Research|May 1, 1992
Experimental tumor inhibitory and toxic properties of the mitomycin A analogue 7-(2-hydroxyethoxy) mitosane (BMY-25551)W T Bradner, J J Catino, B H Long, et al.Cancer Research|October 1, 1991
Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell linesB H Long, L Wang, A Lorico, et al.Cancer Research|December 1, 1984
Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterationsJ K Willson, B H Long, M E Marks, et al.Rapid Communications in Mass Spectrometry : RCM|June 11, 1998
Cellular uptake profile of paclitaxel using liquid chromatography tandem mass spectrometryE H Kerns, S E Hill, D J Detlefsen, et al.Bioorganic & Medicinal Chemistry Letters|July 13, 2000
Structure-activity relationships study at the 3'-N position of paclitaxel. Part 2: synthesis and biological evaluation of 3'-N-thiourea- and 3'-N-thiocarbamate-bearing paclitaxel analoguesM Xue, B H Long, C Fairchild, et al.Journal of Biomolecular Structure & Dynamics|December 1, 1994
Fluorescence polarization studies of the binding of BMS 181176 to DNAB S Krishnan, M E Moore, C P Lavoie, et al.Pageof 4